During the third quarter, Cullen Frost Bankers Inc. increased its holdings in Intuitive Surgical by 4.4%, acquiring 3,450 additional shares to reach a total position of 82,056 shares valued at approximately 36.7 million dollars. Other notable adjustments included Commerzbank Aktiengesellschaft FI adding 752 shares to hold 11,802 shares, Whittier Trust Co. of Nevada lifting its position by 8.8% to 49,093 shares, Whittier Trust Co. boosting its stake by 7.7% to 100,093 shares, CIBC Asset Management Inc. growing its holdings by 1.3% to 159,566 shares, and Robocap Asset Management Ltd expanding its position by 27.2% to 14,542 shares. Institutional and hedge fund ownership now stands at over 83% of the outstanding shares.

Research firms have recently reiterated and raised their assessments of the company’s long-term prospects. One major brokerage upgraded its view to 'outperform', while two others reaffirmed 'buy' recommendations. Across the street, a consensus of 26 analysts includes one strong buy, fifteen buy, nine hold and one sell rating. Analysts cite robust procedural growth, expanding installed base and strength in recurring instrument and accessory revenue as key drivers supporting their positive stance.

Senior vice president Mark Brosius sold 464 shares in mid-December, reducing his direct holding by nearly 78% to 131 shares, in a transaction disclosed with the SEC. Earlier in November, director Craig H. Barratt divested 750 shares. Collectively, insiders have sold over 55,700 shares during the past quarter, representing a total value of approximately 31.6 million dollars, while insider ownership remains below 1% of the total float.

The company reported adjusted earnings per share of 2.53 dollars for its fiscal fourth quarter, surpassing consensus estimates by 0.26 dollars. Revenue rose 18.8% year-over-year to 2.87 billion dollars, driven by a 17% increase in procedures performed with the flagship platform and a 44% jump in procedures using the newer tissue-acquisition system. System placements during the quarter included 532 units of the core platform, expanding the installed base by 12%, while instrument and accessory revenue grew 17%. For the full year, management forecasts procedure growth of 13% to 15% and anticipates maintaining a non-GAAP gross margin in the high-sixties percentage range.